You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › February › 23
Eli
5 months ago
Lilly shares rose more than 4% Monday, while rival Novo Nordisk tanked.
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen ⊕
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
page 1 of 1